When treatment is interrupted for four weeks or longer, the body's adaptation to the medication diminishes, and gastrointestinal tolerance is lost
Genetic Testing and Personalized Semaglutide Therapy Not all patients respond identically to semaglutide, partly because genetic variation affects GLP-1 receptor expression and signaling efficiency
Gradual changes are easier to embrace and incorporate into long-term habits
This process can leave your stool hard, dry, and difficult to pass, resulting in an infrequent or strained bowel movement
Personalization and Genetic Insights for GLP-1 Response The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways
If your results show stronger GLP1R activation patterns, semaglutide may deliver superior results